Literature DB >> 18676659

Concentration dependence of alpha-synuclein fibril length assessed by quantitative atomic force microscopy and statistical-mechanical theory.

Martijn E van Raaij1, Jeroen van Gestel, Ine M J Segers-Nolten, Simon W de Leeuw, Vinod Subramaniam.   

Abstract

The initial concentration of monomeric amyloidogenic proteins is a crucial factor in the in vitro formation of amyloid fibrils. We use quantitative atomic force microscopy to study the effect of the initial concentration of human alpha-synuclein on the mean length of mature alpha-synuclein fibrils, which are associated with Parkinson's disease. We determine that the critical initial concentration, below which low-molecular-weight species dominate and above which fibrils are the dominant species, lies at approximately 15 muM, in good agreement with earlier measurements using biochemical methods. In the concentration regime where fibrils dominate, we find that their mean length increases with initial concentration. These results correspond well to the qualitative predictions of a recent statistical-mechanical model of amyloid fibril formation. In addition, good quantitative agreement of the statistical-mechanical model with the measured mean fibril length as a function of initial protein concentration, as well as with the fibril length distributions for several protein concentrations, is found for reasonable values of the relevant model parameters. The comparison between theory and experiment yields, for the first time to our knowledge, an estimate of the magnitude of the free energies associated with the intermolecular interactions that govern alpha-synuclein fibril formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676659      PMCID: PMC2576393          DOI: 10.1529/biophysj.107.127464

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  31 in total

1.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.

Authors:  L C Serpell; J Berriman; R Jakes; M Goedert; R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

Review 2.  Amyloid fibrillogenesis: themes and variations.

Authors:  J C Rochet; P T Lansbury
Journal:  Curr Opin Struct Biol       Date:  2000-02       Impact factor: 6.809

3.  A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy.

Authors:  Ritu Khurana; Cristian Ionescu-Zanetti; Maighdlin Pope; Jie Li; Liza Nielson; Marina Ramírez-Alvarado; Lynn Regan; Anthony L Fink; Sue A Carter
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

4.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

5.  Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy.

Authors:  Ralf Jansen; Wojciech Dzwolak; Roland Winter
Journal:  Biophys J       Date:  2004-12-01       Impact factor: 4.033

Review 6.  Kinetics and thermodynamics of amyloid fibril assembly.

Authors:  Ronald Wetzel
Journal:  Acc Chem Res       Date:  2006-09       Impact factor: 22.384

7.  Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from alpha-synuclein mutants.

Authors:  Martijn E van Raaij; Ine M J Segers-Nolten; Vinod Subramaniam
Journal:  Biophys J       Date:  2006-09-22       Impact factor: 4.033

8.  Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease?

Authors:  Mark D Shtilerman; Tomas T Ding; Peter T Lansbury
Journal:  Biochemistry       Date:  2002-03-26       Impact factor: 3.162

9.  alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease.

Authors:  S J Wood; J Wypych; S Steavenson; J C Louis; M Citron; A L Biere
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

10.  The effect of macromolecular crowding on protein aggregation and amyloid fibril formation.

Authors:  Larissa A Munishkina; Elisa M Cooper; Vladimir N Uversky; Anthony L Fink
Journal:  J Mol Recognit       Date:  2004 Sep-Oct       Impact factor: 2.137

View more
  17 in total

1.  Supramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation.

Authors:  Jonathan A Fauerbach; Dmytro A Yushchenko; Sarah H Shahmoradian; Wah Chiu; Thomas M Jovin; Elizabeth A Jares-Erijman
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process.

Authors:  Erik Hellstrand; Barry Boland; Dominic M Walsh; Sara Linse
Journal:  ACS Chem Neurosci       Date:  2009-10-09       Impact factor: 4.418

3.  What drives amyloid molecules to assemble into oligomers and fibrils?

Authors:  Jeremy D Schmit; Kingshuk Ghosh; Ken Dill
Journal:  Biophys J       Date:  2011-01-19       Impact factor: 4.033

4.  A lattice-gas model for amyloid fibril aggregation.

Authors:  Liu Hong; Xianghong Qi; Yang Zhang
Journal:  Europhys Lett       Date:  2011-06-08       Impact factor: 1.947

5.  Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.

Authors:  Thai Leong Yap; James M Gruschus; Arash Velayati; Wendy Westbroek; Ehud Goldin; Nima Moaven; Ellen Sidransky; Jennifer C Lee
Journal:  J Biol Chem       Date:  2011-06-08       Impact factor: 5.157

6.  Modification of C Terminus Provides New Insights into the Mechanism of α-Synuclein Aggregation.

Authors:  Kseniia Afitska; Anna Fucikova; Volodymyr V Shvadchak; Dmytro A Yushchenko
Journal:  Biophys J       Date:  2017-09-20       Impact factor: 4.033

7.  Modulation of alpha-synuclein aggregation by dopamine analogs.

Authors:  Diane Latawiec; Fernando Herrera; Alpan Bek; Valeria Losasso; Michela Candotti; Federico Benetti; Elvio Carlino; Agata Kranjc; Marco Lazzarino; Stefano Gustincich; Paolo Carloni; Giuseppe Legname
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

8.  Amyloids of alpha-synuclein affect the structure and dynamics of supported lipid bilayers.

Authors:  Aditya Iyer; Nils O Petersen; Mireille M A E Claessens; Vinod Subramaniam
Journal:  Biophys J       Date:  2014-06-17       Impact factor: 4.033

9.  Amyloid fibril length distribution quantified by atomic force microscopy single-particle image analysis.

Authors:  Wei-Feng Xue; Steve W Homans; Sheena E Radford
Journal:  Protein Eng Des Sel       Date:  2009-07-06       Impact factor: 1.650

10.  Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.

Authors:  Gaia Codolo; Nicoletta Plotegher; Tommaso Pozzobon; Marco Brucale; Isabella Tessari; Luigi Bubacco; Marina de Bernard
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.